Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.53 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL527476 | 1.00 | MAPT (0.59) | MAPTGPR84FFAR1LCKPPARD | |
| SCHEMBL970515 | 1.00 | MAPT (0.59) | MAPTGPR84FFAR1LCKPPARD | |
| SCHEMBL10923278 | 1.00 | MAPT (0.59) | MAPTGPR84FFAR1LCKPPARD | |
| SCHEMBL4002470 | 1.00 | MAPT (0.59) | MAPTGPR84FFAR1LCKPPARD | |
| SCHEMBL6539103 | 0.98 | MAPT (0.55) | MAPTGPR84FFAR1LCKPPARD | |
| SCHEMBL1401236 | 0.91 | CA2 (0.50) | MAPTGPR84FFAR1LCKPPARD | |
| SCHEMBL5158482 | 0.83 | MAPT (0.48) | MAPTGPR84FFAR1LCKPPARD | |
| SCHEMBL11329644 | 0.83 | MAPT (0.48) | MAPTGPR84FFAR1LCKPPARD | |
| SCHEMBL8458707 | 0.83 | MAPT (0.48) | MAPTGPR84FFAR1LCKPPARD | |
| SCHEMBL3127134 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4126003-A1 | GLP-1/GLP-2 DUAL AGONISTS | Zealand Pharma A/S (DK) | 2023-02-08 | — | — | EP | disclosed |
| WO-2021198196-A1 | GLP-1/GLP-2 DUAL AGONISTS | ZEALAND PHARMA A/S (DK) | 2021-10-07 | — | — | WO | disclosed |
| CN-1264307-B | Method of enhancing function of upper gastrointestinal tract | ONTARIO INC 1149336 | 2013-10-30 | — | — | CN | disclosed |
| EP-0981362-B1 | USE OF GLP-2 AGONISTS ENHANCING FUNCTIONING OF THE UPPER GASTROINTESTINAL TRACT | ONTARIO INC 1149336 (CA) | 2003-11-05 | — | — | EP | disclosed |
| US-6458924-B2 | POLYPEPTIDE DRUG; ANTIDIABETIC AGENT; Liraglutide | NOVO NORDISK A/S (DK) | 2002-10-01 | — | — | US | disclosed |
| CN-1264307-A | Method of enhancing function of upper gastrointestinal tract | ONTARIO INC 1149336 (CA) | 2000-08-23 | — | — | CN | disclosed |
| WO-1998052600-A9 | METHODS OF ENHANCING FUNCTIONING OF THE UPPER GASTROINTESTINAL TRACT | ONTARIO INC 1149336 (CA) | 2000-03-09 | — | — | WO | disclosed |
| EP-0981362-A1 | METHODS OF ENHANCING FUNCTIONING OF THE UPPER GASTROINTESTINAL TRACT | 1149336 ONTARIO INC. (CA) | 2000-03-01 | — | — | EP | disclosed |
| WO-1998052600-A1 | METHODS OF ENHANCING FUNCTIONING OF THE UPPER GASTROINTESTINAL TRACT | 1149336 ONTARIO INC. (CA) | 1998-11-26 | — | — | WO | disclosed |